For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
The lovely bones
+News
The lovely bones
Friday 31 August 2018, 12:23 PM
The cost of treating fractures in New Zealand is estimated to be over $300 million a year
Contributor Gayle Robins rounds up the clinical education content in the latest issue of New Zealand Doctor. Use the embedded links to go through to the relevant ELearning page
You will be wondering what director Peter Jackson’s movie The Lovely Bones, first released in New Zealand, has to do with the 29 August issue of New Z
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.